Clinical trials: sponsored by CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Non-Hodgkin's Lymphoma
A Study of Mitoxantrone Hydrochloride Liposome Infusion
This is a Phase 1/2, open-label, multicenter study.
- Trial name
- NCT02856685
- Testing
- Mitoxantrone Hydrochloride Liposome
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Acute Myeloid Leukemia
A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Patients will receive oral SKLB1028 for 28 days to study the side effects, tolerability and best dose for treating relapsed or refractory acute myeloid leukemia With FLT3 Mutations.
- Trial name
- NCT02859948
- Testing
- SKLB1028
- Where
- China
- Volunteers
- 18 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Ischemic Stroke
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
This research is a Randomized, double-blind, placebo-controlled, multicenter clinical study. Chinese subjects with Ischemic Stroke.
- Trial name
- NCT02059785
- Testing
- Pinocembrin for Injection
- Where
- China
- Volunteers
- 216 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Schizophrenia
Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia
This research is a Randomized, double-blind, risperidone-controlled, multicenter clinical study. Chinese subjects with Ischemic Schizophrenia.
- Trial name
- NCT02453893
- Testing
- Iloperidone, Risperidone
- Where
- China
- Volunteers
- 288 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Malignant Lymphoma
Phase I Study of Mitoxantrone Hydrochloride Liposome Injection
The purpose of this study is to determine the maximum tolerated dose,the safety and effectiveness of Mitoxantrone Hydrochloride Liposome Injection.
- Trial name
- NCT02131688
- Testing
- Mitoxantrone Hydrochloride Liposome
- Where
- China
- Volunteers
- 30 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Neoplasms
Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection
The purpose of the study is to examine the toxicity profile, maximum tolerated dose (MTD), and pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection.
- Trial name
- NCT02043756
- Testing
- Mitoxantrone Hydrochloride Liposome, Mitoxantrone
- Volunteers
- 20 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Type 2 Diabetes
The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
This research is randomized, controlled trial. 36 Chinese subjects with Type 2 Diabetes Mellitus will take part in the trial. Subjects will randomly enter into one of three groups, administration daily twice, the period of is 84…
- Trial name
- SPPS (NCT01342042)
- Testing
- rExenatide-4
- Where
- China
- Volunteers
- 36 people
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.